相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemokine/cytokine gene transcription within niche cells
Chiemi Nishida et al.
BLOOD (2012)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease
Sonia D'Souza et al.
BLOOD (2011)
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients
P. Storti et al.
LEUKEMIA (2011)
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
S. K. Martin et al.
LEUKEMIA (2011)
Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug
Jinsong Hu et al.
BLOOD (2010)
Advances in the understanding of myeloma bone disease and tumour growth
Shmuel Yaccoby
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Hypoxia stimulates osteoclast formation from human peripheral blood
Jennifer C. Utting et al.
CELL BIOCHEMISTRY AND FUNCTION (2010)
Targeting the bone microenvironment in multiple myeloma
G. David Roodman
JOURNAL OF BONE AND MINERAL METABOLISM (2010)
Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells
S. Colla et al.
LEUKEMIA (2010)
Targeting Angiogenesis via a c-Myc/Hypoxia-Inducible Factor-1α-Dependent Pathway in Multiple Myeloma
Jing Zhang et al.
CANCER RESEARCH (2009)
Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan
Yongzhen Hu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors
H. F. S. Negaard et al.
LEUKEMIA (2009)
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Gregg L. Semenza
SEMINARS IN CANCER BIOLOGY (2009)
Turn me on: regulating HIF transcriptional activity
K. Lisy et al.
CELL DEATH AND DIFFERENTIATION (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Biology of HIF-1 alpha
A. Weidemann et al.
CELL DEATH AND DIFFERENTIATION (2008)
Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
Anurag Purushothaman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Lee M. Greenberger et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia
Aline Bozec et al.
NATURE (2008)
HIF-1 regulation: not so easy come, easy go
Mei Yee Koh et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 α (HIF-1α) activity:: involvement in myeloma-induced angiogenesis
Simona Colla et al.
BLOOD (2007)
The malignant clone and the bone-marrow environment
Klaus Podar et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Hypoxia and cancer
M. Christiane Brahimi-Horn et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Hypoxia: A key regulator of angiogenesis in cancer
Debbie Liao et al.
CANCER AND METASTASIS REVIEWS (2007)
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells
Simona Colla et al.
BLOOD (2007)
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer
Toru Hiraga et al.
CANCER RESEARCH (2007)
Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib
Lorenzo Veschini et al.
BLOOD (2007)
Regulation of angiogenesis by hypoxia-inducible factor 1
Kiichi Hirota et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients
S Colla et al.
LEUKEMIA (2005)
Evaluating hypoxia-inducible factor-1α as a cancer therapeutic target via inducible RNA interference in vivo
LM Li et al.
CANCER RESEARCH (2005)
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
K Podar et al.
BLOOD (2005)
The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma
MG Alexandrakis et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
To the editor: Do human myeloma cells directly produce basic FGF?
S Colla et al.
BLOOD (2003)
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis
N Giuliani et al.
BLOOD (2003)
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma
G Bisping et al.
BLOOD (2003)
Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes:: a potential role in multiple myeloma bone disease
N Giuliani et al.
BLOOD (2002)
Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells
E Van Valckenborgh et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells
BK Arendt et al.
LEUKEMIA (2002)
Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis
NC Munshi et al.
SEMINARS IN ONCOLOGY (2001)
Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression
VS Shapiro et al.
BLOOD (2001)
分享论文
